Enrichment of ovarian cancer cell suspensions by centrifugal elutriation after density gradient purification

International Journal of Gynecological Cancer

Volumn 7, Issue 2, 1997, Pages 100-105

  Guidozzi, F ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

centrifugal elutriation; enrichment; ovarian cancer cell suspensions

Indexed keywords

MONOCLONAL ANTIBODY CC49; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CELL; CELL SEPARATION; CELL SUSPENSION; CLINICAL ARTICLE; DENSITY GRADIENT CENTRIFUGATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PURIFICATION;

EID: 0030914447     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00426.x     Document Type: Article

References (31)

1. Visscher DW, Crissman JD. Dissociation of intact cells from tumors and normal tissues. Method Cell Biol 1994; 41: 1-13.
2. Guidozzi F, Reddy S, Wadee A. Characterization of peripheral blood and ovarian cancer-infiltrating lymphocytes: Effect of HIV infection on phenotypic expression and proliferative response. Gynecol Oncol 1994; 53: 252-5.
3. Milscher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986; 136: 1899-907.
4. Allavena P, Introna M, Sessa C, Mangioni C, Mantovani A. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells. JNCI 1982; 68: 555-62.
5. Heo DS, Whiteside TL, Kanbour A, Herberman RB. Lymphocytes infiltrating human ovarian tumors. J Immunol 1988; 140: 4042-9.
6. Ioannides CG, Freedman RS, Platsoucas CD, Rashed S, Kim YP. Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J Immunol 1991; 146: 1700-7.
7. Burger RA, Grosen EA, Ioli GR, et al. Host-tumor interaction in ovarian cancer. Gynecol Oncol 1994; 55: 294-303.
8. Grolina DJ, Hittelman WN, White RA, Meistrich ML. Relevance of density size and DNA content of tumor cells to the lung colony assay. Br J Cancer 1977; 36: 659-69.
9. Moore K, Mortari F. Fractionation of human tumor-associated cells by centrifugal elutriation to establish lymphocyte, macrophage and tumor cell culture from a single tumor biopsy. Br J Pathol 1983; 64: 354-60.
10. Keng, PC, Wheeler KT, Sieman DW, Lord EM. Direct synchronization of cells from solid tumors by centrifugal elutriation. Exp Cell Res 1981; 134: 15-22.
11. Loos H, Blok-Schut B, Doorn RV, Hoksbergen R, de la Riviera AR, Meerhof L. A method of recognition and separation of human blood monocytes on density gradients. Blood 1976; 48: 731-42.
12. Dettman GL, Wilbur SM. Colloidal silica-aliminium modified - PUP density gradient centrifugation: centrifuge tube wall cell adherence, aggregation separated properties and comparison to BSA and Ficoll. J Immunol Method 1979; 27: 205-17.
13. Pertoft H, Laurent T. Sedimentation of cells in collidal silica (Percol) In: Pretlow TG, Pretlow TL eds. Cell Separation Methods and Selective Applications. New York: Academic Press, 1982: 115-52.
14. Merstrich ML. Experimental factors involved in separation by centrifugal elutriation. In: Pretlow TG, Pretlow TL eds. Cell Separation Methods and Selective Applications. New York: Academic Press, 1982: 33-59.
15. Molinolo A, Simpson JF, Thor A, Schlom J. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Cancer Res 1990; 50: 1291-8.
16. Milenic DE, Yokota T, Filpula DR, et al. Construction, binding properties metabolism and tumor targeting of a single-chain FV derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 1991; 51: 6363-71.
17. Katari RS, Ferstein PD, Schlom J. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas. Cancer Res 1990; 50: 4885-90.
18. Thor A, Gerstein F, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Tumor associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. J Natl Cancer Inst 76: 995-1006.
19. Sheer DG, Schlom J, Cooper HL. Purification and composition of the human tumor associated glycoprotein (TAG-72 defined by monoclonal antibodies CC49 and B72.3. Cancer Res 1988; 48: 6811-18.
20. Johnston WW, Szpak CA, Lottich SC, Thor A, Schlom J. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions. Cancer Res 1985; 45: 1894-900.
21. Martin SE, Moshiri S, Thor A, Vilasi V, Chu EW, Schlom J. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3. Am J Clin Pathol 1986; 86: 10-18.
22. Negishi Y, Iwabuchi H, Sakunaga H, et al. Serum and tissue measurements of CA72-4 in ovarian cancer patients. Gynecol Oncol 1993; 48: 148-54.
23. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981; 29: 577-80.
24. Colcher D, Hand PH, Teramoto YA, Wunderlich D, Schlom J. Use of monoclonal antibodies to define the diversity of mammary tumor viral gene products in virons and mammary tumors of the genes. Mus Cancer Res 1981; 41: 1451-9.
25. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H, Hakomori S. Preparation and characterization of monoclonal antibodies detected to the tumor-associated O-linked sialosyl-2-6-N-acetylgalactosaminyl (Sialosyl-Tn) epitope Cancer Res 1988; 48: 2214-20.
26. Muraro R, Kuroki M, Wunderlich D, et al. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with tumor-associated glycoprotein 72 antigen. Cancer Res 1988; 48: 4588-96.
27. Gallion HH, Powell DE, Smith LW, Vaugh CC, Case EA. Cytogenic changes in human epithelial ovarian cancer. In: Sharp, F, Mason WP, Creasman W. eds. Ovarian Cancer 2. Biology, Diagnosis and Management. London: Chapman and Hall Medical, 1990: 17-22.
28. Rockwell S. In vivo in vitro tumor cell lines: characteristics and limitations as models for human cancer. Br J Cancer 1980; 41: 118-21.
29. Balkwill FR, Malik STA, Griffin DB. Animal models of ovarian cancer. In: Sharp F, Mason WP, Creasman W. eds. Ovarian Cancer 1. Biological and Therapeutic Challenges. London: Chapman and Hall Medical, 1990: 37-41.
30. Bookman MA. Biologic therapy in the management of refractory ovarian cancer. Gynecol Oncol 1993; 51: 113-26.
31. Santoso JT, Tang D-C, Lane SB, et al. Adenovirus-based 53 gene therapy in ovarian cancer. Gynecol Oncol 1995; 59: 171-8.